Azzad Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.71M Buy
5,597
+55
+1% +$56.2K 0.59% 33
2026
Q1
$5.1M Sell
5,542
-82
-1% -$83.1K 0.52% 47
2025
Q4
$6.04M Sell
5,624
-119
-2% -$114K 0.59% 28
2025
Q3
$4.38M Buy
5,743
+989
+21% +$736K 0.43% 66
2025
Q2
$3.71M Buy
4,754
+21
+0.4% +$16.3K 0.4% 75
2025
Q1
$3.91M Buy
+4,733
New +$3.94M 0.46% 58
2024
Q4
Sell
-1,931
Closed -$1.71M 244
2024
Q3
$1.71M Buy
1,931
+196
+11% +$176K 0.19% 187
2024
Q2
$1.57M Sell
1,735
-79
-4% -$63.2K 0.19% 187
2024
Q1
$1.41M Buy
1,814
+45
+3% +$32K 0.16% 197
2023
Q4
$1.03M Buy
1,769
+623
+54% +$364K 0.13% 213
2023
Q3
$616K Buy
1,146
+106
+10% +$54.6K 0.09% 248
2023
Q2
$488K Sell
1,040
-149
-13% -$62.5K 0.07% 276
2023
Q1
$408K Sell
1,189
-67
-5% -$22.6K 0.06% 285
2022
Q4
$460K Sell
1,256
-10,757
-90% -$3.81M 0.07% 273
2022
Q3
$2.17M Sell
12,013
-3,355
-22% -$1.06M 0.22% 154
2022
Q2
$3.26M Buy
15,368
+11,279
+276% +$3.39M 0.32% 106
2022
Q1
$1.17M Buy
4,089
+640
+19% +$165K 0.17% 201
2021
Q4
$953K Sell
3,449
-134
-4% -$34K 0.13% 246
2021
Q3
$828K Buy
3,583
+162
+5% +$40K 0.12% 250
2021
Q2
$785K Sell
3,421
-24
-0.7% -$4.82K 0.12% 258
2021
Q1
$644K Sell
3,445
-8,954
-72% -$1.75M 0.11% 255
2020
Q4
$2.09M Buy
12,399
+133
+1% +$19.9K 0.38% 102
2020
Q3
$1.82M Buy
12,266
+1,494
+14% +$231K 0.38% 98
2020
Q2
$1.77M Sell
10,772
-1,287
-11% -$198K 0.42% 83
2020
Q1
$1.67M Sell
12,059
-10,691
-47% -$1.47M 0.49% 60
2019
Q4
$3.34M Buy
22,750
+94
+0.4% +$10.9K 0.39% 87
2019
Q3
$3.1M Buy
22,656
+8,713
+62% +$970K 0.38% 89
2019
Q2
$1.54M Sell
13,943
-51
-0.4% -$6.01K 0.42% 88
2019
Q1
$1.82M Buy
13,994
+10
+0.1% +$1.22K 0.53% 53
2018
Q4
$1.62M Sell
13,984
-3,862
-22% -$431K 0.55% 47
2018
Q3
$1.92M Sell
17,846
-224
-1% -$22.4K 0.51% 48
2018
Q2
$1.54M Buy
18,070
+304
+2% +$25K 0.44% 69
2018
Q1
$1.37M Buy
17,766
+405
+2% +$32.6K 0.42% 81
2017
Q4
$1.47M Buy
17,361
+332
+2% +$28.2K 0.46% 70
2017
Q3
$1.46M Buy
17,029
+580
+4% +$47.6K 0.49% 64
2017
Q2
$1.35M Buy
16,449
+2,464
+18% +$201K 0.49% 59
2017
Q1
$1.18M Buy
13,985
+579
+4% +$46.4K 0.44% 80
2016
Q4
$986K Sell
13,406
-1,089
-8% -$81.1K 0.41% 84
2016
Q3
$1.16M Sell
14,495
-170
-1% -$13.6K 0.48% 75
2016
Q2
$1.15M Buy
14,665
+236
+2% +$17.8K 0.49% 70
2016
Q1
$1.04M Buy
14,429
+586
+4% +$44.3K 0.45% 81
2015
Q4
$1.17M Sell
13,843
-1,447
-9% -$120K 0.56% 53
2015
Q3
$1.28M Sell
15,290
-1,016
-6% -$85.8K 0.68% 30
2015
Q2
$1.36M Sell
16,306
-2,113
-11% -$161K 0.69% 27
2015
Q1
$1.34M Buy
18,419
+798
+5% +$56.8K 0.64% 32
2014
Q4
$1.22M Buy
17,621
+3,502
+25% +$236K 0.64% 32
2014
Q3
$916K Buy
14,119
+8,303
+143% +$526K 0.53% 46
2014
Q2
$362K Sell
5,816
-19
-0.3% -$1.13K 0.22% 197
2014
Q1
$343K Buy
5,835
+133
+2% +$7.42K 0.23% 193
2013
Q4
$291K Buy
5,702
+406
+8% +$20.3K 0.21% 198
2013
Q3
$267K Hold
5,296
0.22% 186
2013
Q2
$267K Buy
+5,296
New +$288K 0.23% 182

Other funds holding LLY

Azzad Asset Management's LLY Position: Q2 2026 in Review

Azzad Asset Management increased its Eli Lilly (LLY) stake by 0.99% in Q2 2026, buying an estimated $56.2K and bringing the position to 5,597 shares worth $6.71M. The position accounts for 0.59% of the portfolio, ranked #33.

Azzad Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Azzad Asset Management held 5,597 shares of Eli Lilly worth $6.71M as of Q2 2026.
  • Azzad Asset Management bought 55 Eli Lilly shares in Q2 2026, an estimated $56.2K.
  • Eli Lilly made up 0.59% of Azzad Asset Management's portfolio in Q2 2026, its #33 holding.
  • Azzad Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.